<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-13T19:02:32Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:11351/13054" metadataPrefix="didl">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:11351/13054</identifier><datestamp>2025-10-24T10:25:51Z</datestamp><setSpec>com_2072_378070</setSpec><setSpec>com_2072_378040</setSpec><setSpec>col_2072_378092</setSpec></header><metadata><d:DIDL xmlns:d="urn:mpeg:mpeg21:2002:02-DIDL-NS" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="urn:mpeg:mpeg21:2002:02-DIDL-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/did/didl.xsd">
   <d:DIDLInfo>
      <dcterms:created xmlns:dcterms="http://purl.org/dc/terms/" xsi:schemaLocation="http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/dcterms.xsd">2025-10-24T10:25:51Z</dcterms:created>
   </d:DIDLInfo>
   <d:Item id="hdl_11351_13054">
      <d:Descriptor>
         <d:Statement mimeType="application/xml; charset=utf-8">
            <dii:Identifier xmlns:dii="urn:mpeg:mpeg21:2002:01-DII-NS" xsi:schemaLocation="urn:mpeg:mpeg21:2002:01-DII-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dii/dii.xsd">urn:hdl:11351/13054</dii:Identifier>
         </d:Statement>
      </d:Descriptor>
      <d:Descriptor>
         <d:Statement mimeType="application/xml; charset=utf-8">
            <oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
               <dc:title>Phenotypic Variation in Disease Severity Among Hospitalized Pediatric Patients With COVID-19: Assessing the Impact of COVID-19 in the EPICO Study</dc:title>
               <dc:creator>Sossa-Alarcón, María Camila</dc:creator>
               <dc:creator>Gutierrez Gaitan, Monica Paola</dc:creator>
               <dc:creator>Becerra Uribe, Natalia</dc:creator>
               <dc:creator>Ortegon, Luz Yessenia</dc:creator>
               <dc:creator>David, María Camila</dc:creator>
               <dc:creator>Naranjo Vanegas, Melisa Sofía</dc:creator>
               <dc:creator>Soriano-Arandes, Antoni</dc:creator>
               <dc:creator>Melendo, Susana</dc:creator>
               <dc:subject>COVID-19 (Malaltia)</dc:subject>
               <dc:subject>Infants</dc:subject>
               <dc:subject>Fenotip</dc:subject>
               <dc:subject>Hospitals - Ingressos i altes</dc:subject>
               <dc:subject>Anàlisi de conglomerats</dc:subject>
               <dc:subject>DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections</dc:subject>
               <dc:subject>PHENOMENA AND PROCESSES::Genetic Phenomena::Phenotype</dc:subject>
               <dc:subject>ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Patient Care::Hospitalization</dc:subject>
               <dc:subject>ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Cluster Analysis</dc:subject>
               <dc:subject>NAMED GROUPS::Persons::Age Groups::Child</dc:subject>
               <dc:subject>ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus</dc:subject>
               <dc:subject>FENÓMENOS Y PROCESOS::fenómenos genéticos::fenotipo</dc:subject>
               <dc:subject>TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::asistencia al paciente::hospitalización</dc:subject>
               <dc:subject>TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::métodos epidemiológicos::estadística como asunto::análisis por grupos</dc:subject>
               <dc:subject>DENOMINACIONES DE GRUPOS::personas::Grupos de Edad::niño</dc:subject>
               <dc:description>COVID-19; Inpatients; Pediatrics</dc:description>
               <dc:description>COVID-19; Pacientes hospitalizados; Pediatría</dc:description>
               <dc:description>COVID-19; Pacients hospitalitzats; Pediatria</dc:description>
               <dc:description>Objective: To characterize the clinical phenotypes of SARS-CoV-2 infection in hospitalized children as part of the EPICO multicenter cohort study.&#xd;
Methods: We included hospitalized children with confirmed SARS-CoV-2 infection from Colombian and Spanish institutions to assess disease evolution and outcomes. Cluster analysis was performed to identify clinical phenotypes.&#xd;
Results: A total of 2318 patients were included (55% male, 36% infants). Five phenotype clusters emerged: Cluster 1 (26.5%): infants without comorbidities, low PICU admissions and mortality; Cluster 2 (18.5%): respiratory comorbidities, high microorganism co-detection and mortality; Cluster 3 (11.5%): fever, gastrointestinal symptoms, high PICU admissions; Cluster 4 (32%): mild unspecific symptoms, low mortality; Cluster 5 (11.3%): adolescents without comorbidities, low co-detection and hospitalization rates. Findings were consistent across both countries.&#xd;
Conclusion: Identifying clinical phenotypes of SARS-CoV-2 in children may improve risk stratification and guide future management strategies.</dc:description>
               <dc:description>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This study was fund by the Pediatrics Department at the Universidad de los Andes and Fundación Santa Fe de Bogotá and Pan American Health Organization. The sponsors were not directly involved in the study, meaning that they had no role in the study design, data collection, and report writing.</dc:description>
               <dc:date>2025-10-24T10:25:51Z</dc:date>
               <dc:date>2025-10-24T10:25:51Z</dc:date>
               <dc:date>2025-05-08T11:19:59Z</dc:date>
               <dc:date>2025-05-08T11:19:59Z</dc:date>
               <dc:date>2025-03</dc:date>
               <dc:type>info:eu-repo/semantics/article</dc:type>
               <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
               <dc:identifier>http://hdl.handle.net/11351/13054</dc:identifier>
               <dc:relation>International Journal of Public Health;70</dc:relation>
               <dc:relation>https://doi.org/10.3389/ijph.2025.1607246</dc:relation>
               <dc:rights>Attribution 4.0 International</dc:rights>
               <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
               <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
               <dc:publisher>Frontiers Media</dc:publisher>
               <dc:source>Scientia</dc:source>
            </oai_dc:dc>
         </d:Statement>
      </d:Descriptor>
   </d:Item>
</d:DIDL></metadata></record></GetRecord></OAI-PMH>